Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation
Launched by UNIVERSITY HOSPITAL PADOVA · Dec 11, 2020
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Level III neonatal intensive care unit consultants, pediatric residents, and nurses. Participants will be divided into teams including a consultant and a nurse or a resident and a nurse during the simulation.
- Exclusion Criteria:
- • There are no exclusion criteria for this study.
About University Hospital Padova
University Hospital Padova is a leading research institution in Italy, renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. As a prominent academic medical center, it integrates cutting-edge research with comprehensive healthcare services, fostering collaboration among multidisciplinary teams of experts. The hospital is dedicated to ethical research practices and patient safety, striving to translate scientific discoveries into effective treatments. With a strong emphasis on education and training, University Hospital Padova plays a pivotal role in shaping the future of medicine while contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bolzano, , Italy
Padova, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials